138 related articles for article (PubMed ID: 11962655)
1. In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)/ bioactive glass composites.
Rich J; Jaakkola T; Tirri T; Närhi T; Yli-Urpo A; Seppälä J
Biomaterials; 2002 May; 23(10):2143-50. PubMed ID: 11962655
[TBL] [Abstract][Full Text] [Related]
2. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(epsilon-caprolactone-co-DL-lactide) and bioactive glass (S53P4).
Jaakkola T; Rich J; Tirri T; Närhi T; Jokinen M; Seppälä J; Yli-Urpo A
Biomaterials; 2004 Feb; 25(4):575-81. PubMed ID: 14607495
[TBL] [Abstract][Full Text] [Related]
3. A new generation of poly(lactide/ε-caprolactone) polymeric biomaterials for application in the medical field.
Fernández J; Larrañaga A; Etxeberria A; Wang W; Sarasua JR
J Biomed Mater Res A; 2014 Oct; 102(10):3573-84. PubMed ID: 24243562
[TBL] [Abstract][Full Text] [Related]
4. Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(epsilon-caprolactone-co-D,L-lactide) and bioactive glass S53P4.
Aho AJ; Tirri T; Kukkonen J; Strandberg N; Rich J; Seppälä J; Yli-Urpo A
J Mater Sci Mater Med; 2004 Oct; 15(10):1165-73. PubMed ID: 15516880
[TBL] [Abstract][Full Text] [Related]
5. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part II: In vitro degradation.
Niemelä T; Niiranen H; Kellomäki M
Acta Biomater; 2008 Jan; 4(1):156-64. PubMed ID: 17692583
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure and properties of poly(L-lactide-co-ε-caprolactone) statistical copolymers.
Fernández J; Etxeberria A; Sarasua JR
J Mech Behav Biomed Mater; 2012 May; 9():100-12. PubMed ID: 22498288
[TBL] [Abstract][Full Text] [Related]
7. Bone response to degradable thermoplastic composite in rabbits.
Närhi TO; Jansen JA; Jaakkola T; de Ruijter A; Rich J; Seppälä J; Yli-Urpo A
Biomaterials; 2003 May; 24(10):1697-704. PubMed ID: 12593950
[TBL] [Abstract][Full Text] [Related]
8. New generation poly(ε-caprolactone)/gel-derived bioactive glass composites for bone tissue engineering: Part I. Material properties.
Dziadek M; Menaszek E; Zagrajczuk B; Pawlik J; Cholewa-Kowalska K
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():9-21. PubMed ID: 26249560
[TBL] [Abstract][Full Text] [Related]
9. Bioactive glass induced in vitro apatite formation on composite GBR membranes.
Tirri T; Rich J; Wolke J; Seppälä J; Yli-Urpo A; Närhi TO
J Mater Sci Mater Med; 2008 Aug; 19(8):2919-23. PubMed ID: 18360801
[TBL] [Abstract][Full Text] [Related]
10. Sol-gel derived nanoscale bioactive glass (NBG) particles reinforced poly(ε-caprolactone) composites for bone tissue engineering.
Lei B; Shin KH; Noh DY; Jo IH; Koh YH; Kim HE; Kim SE
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1102-8. PubMed ID: 23827548
[TBL] [Abstract][Full Text] [Related]
11. Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites.
Rich J; Kortesuo P; Ahola M; Yli-Urpo A; Kiesvaara J; Seppälä J
Int J Pharm; 2001 Jan; 212(1):121-30. PubMed ID: 11165827
[TBL] [Abstract][Full Text] [Related]
12. Processing and properties of porous poly(L-lactide)/bioactive glass composites.
Zhang K; Wang Y; Hillmyer MA; Francis LF
Biomaterials; 2004 Jun; 25(13):2489-500. PubMed ID: 14751733
[TBL] [Abstract][Full Text] [Related]
13. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part I: Initial mechanical properties and bioactivity.
Niemelä T; Niiranen H; Kellomäki M; Törmälä P
Acta Biomater; 2005 Mar; 1(2):235-42. PubMed ID: 16701800
[TBL] [Abstract][Full Text] [Related]
14. Properties of epsilon-caprolactone/DL-lactide (epsilon-CL/DL-LA) copolymers with a minor epsilon-CL content.
Hiljanen-Vainio MP; Orava PA; Seppälä JV
J Biomed Mater Res; 1997 Jan; 34(1):39-46. PubMed ID: 8978651
[TBL] [Abstract][Full Text] [Related]
15. In vitro behaviour of three biocompatible glasses in composite implants.
Varila L; Lehtonen T; Tuominen J; Hupa M; Hupa L
J Mater Sci Mater Med; 2012 Oct; 23(10):2425-35. PubMed ID: 22669284
[TBL] [Abstract][Full Text] [Related]
16. Poly(epsilon-caprolactone-co-D,L-lactide) /silk fibroin composite materials: preparation and characterization.
Kesenci K; Motta A; Fambri L; Migliaresi C
J Biomater Sci Polym Ed; 2001; 12(3):337-51. PubMed ID: 11484941
[TBL] [Abstract][Full Text] [Related]
17. Hydrolytic degradation of composites of poly(L-lactide-co-epsilon-caprolactone) 70/30 and β-tricalcium phosphate.
Ahola N; Veiranto M; Rich J; Efimov A; Hannula M; Seppälä J; Kellomäki M
J Biomater Appl; 2013 Nov; 28(4):529-43. PubMed ID: 23048066
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo behavior of self-reinforced bioabsorbable polymer and self-reinforced bioabsorbable polymer/bioactive glass composites.
Niiranen H; Pyhältö T; Rokkanen P; Kellomäki M; Törmälä P
J Biomed Mater Res A; 2004 Jun; 69(4):699-708. PubMed ID: 15162412
[TBL] [Abstract][Full Text] [Related]
19. Tensile behavior and dynamic mechanical analysis of novel poly(lactide/δ-valerolactone) statistical copolymers.
Fernández J; Larrañaga A; Etxeberria A; Sarasua JR
J Mech Behav Biomed Mater; 2014 Jul; 35():39-50. PubMed ID: 24732304
[TBL] [Abstract][Full Text] [Related]
20. Resorbable composites with bioresorbable glass fibers for load-bearing applications. In vitro degradation and degradation mechanism.
Lehtonen TJ; Tuominen JU; Hiekkanen E
Acta Biomater; 2013 Jan; 9(1):4868-77. PubMed ID: 22963847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
